Abstract
Background
This study aimed to determine if the cerebrospinal fluid (CSF) cell count is useful for predicting the infection severity or prognosis in Japanese adults with community-acquired bacterial meningitis.
Methodology
This study retrospectively evaluated the prognosis of patients diagnosed with community-acquired bacterial meningitis at our hospital from January 2004 to December 2021 using the modified Rankin scale (mRs) (Showa General Hospital; N = 39). Patients were classified into the following two groups: (i) favorable (mRs: 0-3) and (ii) unfavorable (mRs: 4-6). Eight factors were selected and compared with outcomes, and then two factors were evaluated from those, and a multivariate logistic regression was used to determine the significant variables.
Results
CSF cell count was observed to be associated with poor prognoses (odds ratio (OR) = 0.86, 95% confidence interval (CI) = 0.99995-0.99999, p = 0.0012). Glasgow coma scale (GCS) score on admission was also observed to be associated with poor prognoses (OR = 0.93, 95% CI = 0.89145-0.97290, p = 0.0029).
Conclusions
Low CSF cell count and low GCS on admission were observed as risk factors for poor prognoses in patients with bacterial meningitis.
Keywords: retrospective study, cerebrospinal fluid cell count, japanese, neurologic prognosis, acute bacterial meningitis
Introduction
Bacterial meningitis is a neurological emergency disease and an inflammatory disease of the leptomeninges, which are the tissues surrounding the brain and spinal cord. It is characterized by bacterial infection of the subarachnoid space and cerebral ventricles, with an abnormal number of leukocytes in the cerebrospinal fluid (CSF) in most cases [1]. The mortality rate of bacterial meningitis remains high despite the appropriate use of effective antibiotics, and bacterial meningitis easily results in sequelae. A 2016 study reported that bacterial meningitis caused 318,000 deaths and 21,866,000 disability-adjusted life years annually worldwide [2].
Vaccination against Streptococcus pneumoniae and Haemophilus influenzae type b has dramatically decreased the number of patients with bacterial meningitis both in developed and developing countries. Consequently, the possibility of encountering patients with bacterial meningitis is decreasing [3]. Although the incidence of bacterial meningitis is decreasing, its diagnosis is sometimes difficult because patients often present with symptoms other than the classic triad of meningitis symptoms, including fever, nuchal rigidity, and a change in mental status. Furthermore, a population-based cohort study of community-acquired bacterial meningitis reported that delayed administration of antimicrobial agents negatively impacts patients [4,5]. Thus, the infection severity and prognosis are of interest when treating patients with bacterial meningitis. Unfavorable outcome predictions in patients with bacterial meningitis have been reported to include impaired mental status on admission, seizures, and hypotension. The existing literature includes studies identifying the risk factors for unfavorable outcomes in patients with bacterial meningitis [5,6]. However, studies on Japanese people are relatively fewer than on Caucasians and other Asian populations [5-9]. Therefore, this study retrospectively evaluated the prognoses of patients diagnosed with community-acquired bacterial meningitis at Showa General Hospital, Japan, from January 2004 to December 2021 using the modified Rankin scale (mRs).
Materials and methods
Between January 2004 and December 2021, 208 patients at Showa General Hospital had positive CSF cultures, and two neurologists clinically diagnosed six patients with meningitis. All protocols were approved by the Ethical Committee for Clinical Research at Showa General Hospital (approval number: REC-310), and patients were provided opt-out consent.
Patient activities were evaluated based on their medical records to determine if they could care for themselves 30 days after hospitalization. Next, they were classified using the mRs with scores ranging from 0 to 6. Patients were grouped as those with (i) favorable (mRs: 0-3) and (ii) unfavorable (mRs: 4-6) outcomes. For example, if a patient was discharged home without any sequelae, they were grouped as having favorable outcomes (mRs: 0-3).
All patients were administered empirical antibiotics (meropenem, vancomycin, ceftriaxone, or ampicillin) until bacterial culture and antibiotic susceptibility results were available, after which definitive therapy was initiated. Additionally, dexamethasone was administered as an adjuvant in 22 (56.4%) patients. Neurological or intensive care specialists performed these treatments in accordance with the treatment guidelines.
CSF and blood tests
A blood test and lumbar puncture were performed on all patients upon arrival at the hospital, and antibiotic administration was commenced as soon as possible. Blood tests included hematological, biochemical, and coagulation analyses, while CSF was collected for biochemical and hematological analyses. The blood and CSF were also submitted for microbiological analyses, including Gram staining and culture tests. Although not all patients had a history of diabetes mellitus (DM), those with hemoglobin A1c (HbA1c) levels ≥6.5% and random blood glucose levels ≥200 mg/dL were diagnosed with DM following the Japanese Clinical Practice Guideline for Diabetes 2019 [10]. C-reactive protein (CRP) levels were measured by latex agglutination turbidimetric immunoassay (N-assay LA CRP-T B type, Nittobo Medical, Tokyo, Japan), and elevated CRP levels were defined as higher than 0.5 mg/dL.
Imaging analyses
Cerebral infarction was assessed either by magnetic resonance imaging (MRI) or cranial computed tomography (CT) performed during hospitalization. Patients with (i) a combination of high signals in diffusion-weighted images and low signals in apparent diffusion coefficient maps on MRI or (ii) low-density areas observed in CT images during hospitalization were diagnosed with cerebral infarction. All patients underwent cranial CT, and three could not undergo MRI due to bad clinical statuses, the impossibility of maintaining them at rest, or other problems.
Statistical analyses
Based on previous research and pathophysiology, we compared relationships between outcome and predicting factors, that is, CSF glucose, CSF cell count, the number of days to initiate antibiotics, Glasgow coma scale (GCS) on admission, age, complication of cerebral infarction, DM status, and C-reactive protein (CRP). These analyses were performed using the Wilcoxon signed-rank sum test and chi-square test. As the range of values varied for each variable, the data were normalized, and logistic regression analysis was performed. In logistic regression analysis, we narrowed down variables as CSF glucose and GCS on admission, based on discussions with several clinicians and previous studies [7,8]. We narrowed down the variables because the number of patients was small. Statistical significance was set at p-values equal to 0.05, and all analyses were performed using R software (version 4.1.2).
Results
From a total of 214 patients, 175 were excluded for the following reasons: (i) 34 were <18 years old, (ii) 109 had postoperative and posttraumatic meningitis, (iii) 18 had suspected contamination, (iv) two had hospital-acquired bacterial meningitis, (v) three had fungal meningitis, (vi) six had occupying intracranial lesions, (vi) one had poor activities of daily living before being transferred to the hospital, and (vii) two had insufficient laboratory data. This study included 39 adult patients diagnosed with community-acquired bacterial meningitis (Figure 1, Table 1), of whom 15 (38.5%) were female, and 24 (61.5%) were male. All patients were Japanese, which was confirmed from the medical records. The median age was 64 years (range = 43-83 years), and the median CSF cell count was 2,308/μL3 (range = 20-22,880 /μL3). Causative microorganisms were detected in CSF samples from 33 (84.6%) patients via culture tests or Gram-staining. Streptococcus pneumoniae was the causative organism in 19 (48.7%) patients. The other isolated bacteria included Streptococcus agalactiae (N = 4, 10.3%), Staphylococcus aureus (N = 4, 10.3%), Haemophilus influenzae (N = 1, 0.03%), Neisseria meningitis (N = 1, 0.03%), Serratia plymuthica (N = 1, 0.03%), Campylobacter fetus (N = 1, 0.03%), methicillin-resistant Staphylococcus aureus (N = 1, 0.03%), Staphylococcus capitis (N = 1, 0.03%), Streptococcus suis (N = 1, 0.03%), and other unknown bacteria (N = 5, 12.8%). Blood cultures were positive in 23 (60.0%) patients.
Table 1. Characteristics of patients.
mRs is a scale to present the severity of sequelae in patients, varying from 0 to 6, with 0 referring to normal status.
GCS is a scale to present the consciousness level of patients, varying from 3 to 15, with 15 referring to a normal level of consciousness.
SD = standard deviation; DM = diabetes mellitus; mRs = modified Rankin scale; GCS = Glasgow coma scale; CSF = cerebrospinal fluid; CRP = C-reactive protein
| Characteristics | Number of patients (N = 39) |
| Patient characteristics | |
| Female, n (%) | 15 (39) |
| Age, mean ± SD (years) | 64 ± 13 |
| Cerebral infraction, n (%) | 15 (39) |
| DM, n (%) | 5 (13) |
| mRs in 30 days <3, n (%) | 19 (49) |
| GCS score at presentation, mean ± SD | 11 ± 3 |
| Laboratory features | |
| CSF | |
| CSF protein, mean ± SD (mg/dL) | 460 ± 511 |
| CSF cell count, mean ± SD (/3μL) | 6530 ± 7721 |
| CSF/blood glucose ratio, mean ± SD | 0.2 ± 0.2 |
| Blood | |
| CRP, mean ± SD (mg/dL) | 18 ± 12 |
Figure 1. Selection of patients.
The median CRP level was 15.2 mg/dL (range = 0.15-44.57), and 19 (48.7%) patients had favorable outcomes (mRs: 0-3) after 30 days of hospitalization, while 20 (51.3%) had unfavorable outcomes (mRs: 4-6). Five patients had DM, including those previously diagnosed with DM and those newly diagnosed during hospitalization.
Five potential prognostic factors were associated with outcome and two of them had a strong association with outcomes on multivariable analysis. In non-parametric analysis, CSF cell count (p = 0.03), GCS on admission (p = 0.02), age (p = 0.005), a complication of cerebral infarction (p < 0.001), and CRP (p = 0.007) had relationships with poor prognosis (Table 2). On logistic regression analysis, CSF cell count was observed to be associated with poor prognoses (odds ratio (OR) = 0.86, 95% confidence interval (CI) 0.99995-0.99999, p = 0.0012) (Figure 2, Table 3). Moreover, GCS on admission was also observed to be associated with poor prognoses (OR = 0.93, 95% CI = 0.89145-0.97290, p = 0.0029) (Table 3).
Table 2. Relationships between outcome and predicting factors.
CSF = cerebrospinal fluid; GCS = Glasgow coma scale; DM = diabetes mellitus; CRP = C-reactive protein
| Predictive factor | P-value |
| CSF glucose | 0.98 |
| CSF cell count | 0.026 |
| The number of days to initiate antibiotics | 0.47 |
| GCS on admission | 0.02 |
| Age | 0.0054 |
| Cerebral infarction | <0.0010 |
| DM | 0.31 |
| CRP | 0.0067 |
Table 3. Independent risk factors for unfavorable factors.
CI = Confidence interval; GCS = Glasgow coma scale; CSF = cerebrospinal fluid
| Variable | Odds ratio | 95% CI | P-value |
| CSF cell count | 0.86 | 0.99995-0.99999 | 0.0012 |
| GCS on admission | 0.93 | 0.89145-0.97290 | 0.0029 |
Figure 2. Relationships between CSF cell count and the modified Rankin scale.
CSF = cerebrospinal fluid
Discussion
Mortality rates of bacterial meningitis are still high due to the poor prognoses of patients with bacterial meningitis. In the United States, the mortality rate in adults is 16.4%, which increases with age; the mortality rate in patients between 18 and 34 years old is 8.9%, while the rate in patients >65 years old is 22.7% [5]. Focal abnormalities of the central nervous system, such as hemiparesis, aphasia, and gaze preference, are also observed in 16-28% of adult patients with bacterial meningitis [11,12]. The resulting damages are multifactorial, involving bacterial toxins, cytotoxic products of immunocompetent cells, and indirect pathology secondary to intracranial complications [13]. These abnormalities are mostly caused by cerebral edema, infarction, and hydrocephalus and severely affect patients’ quality of life. Moreover, these causes affect the consciousness of patients [14]. Cerebral infarctions observed in the patients in this study during MRI or CT performed after a few days of hospitalization were suspected to be caused by bacterial meningitis. It was difficult to assume that cerebral infarctions by lacunar, atheromatous, or cardiogenic and bacterial meningitis had occurred simultaneously. Cerebral infarction has been reported in patients with bacterial meningitis caused by Streptococcus pneumoniae, Staphylococcus aureus, and others [14,15].
Furthermore, this study observed a relationship between low CSF cell count and poor prognoses. One previous study reported that almost 2% of patients with community-acquired bacterial meningitis had completely normal initial CSF cell counts, although they did not necessarily have immunodeficiencies [16,17]. Repeated lumbar punctures showed that all patients with normal initial CSF cell counts had higher CSF cell counts than the initial values. The increased values were unrelated to poor prognoses; hence, CSF cell counts might have been measured before they became elevated. However, the authors of the study did not highlight this reason, and it did not include the completely normal CSF cell counts of patients with bacterial meningitis. Hence, their study did not identify the relationship between completely normal CSF cell counts and prognoses in patients with bacterial meningitis.
Additionally, Martijn et al. reported that CSF cell counts <1,000 cells/mm3 were significantly associated with unfavorable outcomes. Other studies also reported that low CSF cell counts were related to poor prognoses with outcomes such as paralysis caused by cerebral infarctions [5,8,18]. The present study also observed a similar trend in Japanese patients and could not identify the relationship between DM, CSF glucose, and the number of days to initiate antibiotics and poor prognoses.
On the other hand, some reviews have shown that granulocytes found in the CSF may imply an increase in neurotoxicity because leukocyte migration into the CSF may cause a blood-brain barrier injury and cerebral edema [13,19,20]. Considering these reviews, minor CSF cell count elevation might occur in cases of bacterial meningitis with low CSF cell counts. Lumbar punctures need to be repeated to observe the CSF cell count transition and confirm this. However, lumbar punctures are invasive and cause several complications. Hence, a repeated lumbar puncture to predict a patient’s prognosis is not a practical option, and additional studies and data are necessary.
This study had several limitations. First, it was a single-center study and the number of included cases was small. Second, data were retrospectively collected. Therefore, a multicenter prospective study with a larger sample size is necessary.
This study could not clarify the reason for low CSF cell counts in patients with bad prognoses. Nonetheless, the relationship between low CSF cell counts and poor prognoses was obvious based on the available data. Furthermore, this observed association between CSF cell counts and prognosis might aid in improving clinical decisions for patients with bacterial meningitis.
Conclusions
This study observed a strong relationship between low CSF cell counts and poor prognoses. However, we did not observe any relationships between poor prognoses and age, CRP, and diabetes mellitus. As the study has some limitations, further research is needed.
Ayaka Sugiura was an employee of Deloitte Analytics, Deloitte Touche Tohmatsu LLC, at the time of the study.
Author Contributions
Concept and design: Yoshiyuki Matsuki, Toshimi Oda, Eri Fukao, Ayaka Sugiura, Takayuki Yokozawa, Yutaka Honma
Acquisition, analysis, or interpretation of data: Yoshiyuki Matsuki, Toshimi Oda, Eri Fukao, Ayaka Sugiura, Takayuki Yokozawa, Yutaka Honma
Drafting of the manuscript: Yoshiyuki Matsuki, Toshimi Oda, Eri Fukao, Ayaka Sugiura, Takayuki Yokozawa, Yutaka Honma
Critical review of the manuscript for important intellectual content: Yoshiyuki Matsuki, Toshimi Oda, Eri Fukao, Ayaka Sugiura, Takayuki Yokozawa, Yutaka Honma
Supervision: Toshimi Oda, Eri Fukao, Ayaka Sugiura, Yutaka Honma
Human Ethics
Consent was obtained or waived by all participants in this study. Clinical Research Ethics Committee of Showa General Hospital issued approval REC-310
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Central nervous system infections in the absence of cerebrospinal fluid pleocytosis. Erdem H, Ozturk-Engin D, Cag Y, et al. Int J Infect Dis. 2017;65:107–109. doi: 10.1016/j.ijid.2017.10.011. [DOI] [PubMed] [Google Scholar]
- 2.Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–480. doi: 10.1016/S1474-4422(18)30499-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Community-acquired bacterial meningitis. van de Beek D, Brouwer M, Hasbun R, Koedel U, Whitney CG, Wijdicks E. Nat Rev Dis Primers. 2016;2:16074. doi: 10.1038/nrdp.2016.74. [DOI] [PubMed] [Google Scholar]
- 4.Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study. Bodilsen J, Dalager-Pedersen M, Schønheyder HC, Nielsen H. BMC Infect Dis. 2016;16:392. doi: 10.1186/s12879-016-1711-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Clinical features and prognostic factors in adults with bacterial meningitis. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. N Engl J Med. 2004;351:1849–1859. doi: 10.1056/NEJMoa040845. [DOI] [PubMed] [Google Scholar]
- 6.A hospital-based study on etiology and prognosis of bacterial meningitis in adults. Sunwoo JS, Shin HR, Lee HS, et al. Sci Rep. 2021;11:6028. doi: 10.1038/s41598-021-85382-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hospital-based study of the prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan. Ishihara M, Kamei S, Taira N, et al. Intern Med. 2009;48:295–300. doi: 10.2169/internalmedicine.48.1508. [DOI] [PubMed] [Google Scholar]
- 8.A risk score for unfavorable outcome in adults with bacterial meningitis. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Ann Neurol. 2008;63:90–97. doi: 10.1002/ana.21216. [DOI] [PubMed] [Google Scholar]
- 9.Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Aronin SI, Peduzzi P, Quagliarello VJ. Ann Intern Med. 1998;129:862–869. doi: 10.7326/0003-4819-129-11_part_1-199812010-00004. [DOI] [PubMed] [Google Scholar]
- 10.Japanese Clinical Practice Guideline for Diabetes 2019. Araki E, Goto A, Kondo T, et al. Diabetol Int. 2020;11:165–223. doi: 10.1007/s13340-020-00439-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bacterial meningitis in the United States, 1998-2007. Thigpen MC, Whitney CG, Messonnier NE, et al. N Engl J Med. 2011;364:2016–2025. doi: 10.1056/NEJMoa1005384. [DOI] [PubMed] [Google Scholar]
- 12.Acute bacterial meningitis in adults. A review of 493 episodes. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN. N Engl J Med. 1993;328:21–28. doi: 10.1056/NEJM199301073280104. [DOI] [PubMed] [Google Scholar]
- 13.Pathophysiology and treatment of bacterial meningitis. Hoffman O, Weber RJ. Ther Adv Neurol Disord. 2009;2:1–7. doi: 10.1177/1756285609337975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Vasculitic presentation of staphylococcal meningitis. Bentley P, Qadri F, Wild EJ, Hirsch NP, Howard RS. Arch Neurol. 2007;64:1788–1789. doi: 10.1001/archneur.64.12.1788. [DOI] [PubMed] [Google Scholar]
- 15.Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Kastenbauer S, Pfister HW. Brain. 2003;126:1015–1025. doi: 10.1093/brain/awg113. [DOI] [PubMed] [Google Scholar]
- 16.Repeat lumbar puncture in adults with bacterial meningitis. Costerus JM, Brouwer MC, van der Ende A, van de Beek D. Clin Microbiol Infect. 2016;22:428–433. doi: 10.1016/j.cmi.2015.12.026. [DOI] [PubMed] [Google Scholar]
- 17.Normocellular community-acquired bacterial meningitis in adults: a nationwide population-based case series. Vestergaard HH, Larsen L, Brandt C, et al. Ann Emerg Med. 2021;77:11–18. doi: 10.1016/j.annemergmed.2020.05.041. [DOI] [PubMed] [Google Scholar]
- 18.Cerebral infarction in bacterial meningitis: predictive factors and outcome. Katchanov J, Heuschmann PU, Endres M, Weber JR. J Neurol. 2010;257:716–720. doi: 10.1007/s00415-009-5395-9. [DOI] [PubMed] [Google Scholar]
- 19.Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD. J Exp Med. 1989;170:959–969. doi: 10.1084/jem.170.3.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.TRAIL limits excessive host immune responses in bacterial meningitis. Hoffmann O, Priller J, Prozorovski T, et al. J Clin Invest. 2007;117:2004–2013. doi: 10.1172/JCI30356. [DOI] [PMC free article] [PubMed] [Google Scholar]


